Abstract
We report here on a 24-year-old patient with Behcet's disease who had been diagnosed with acute transverse myelitis. He was successfully treated with a combination regimen of a steroids, cyclophosphamide, and interferon-alpha. The treatment strategy with specific emphasis on interferon-alpha is discussed in the light of the pertinent literature.
MeSH terms
-
Adult
-
Anti-Bacterial Agents / administration & dosage
-
Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
-
Behcet Syndrome / complications
-
Behcet Syndrome / diagnosis
-
Behcet Syndrome / drug therapy*
-
Drug Administration Routes
-
Drug Therapy, Combination
-
Follow-Up Studies
-
Glucocorticoids / administration & dosage
-
Gout Suppressants / administration & dosage
-
Humans
-
Immunologic Factors / therapeutic use*
-
Immunosuppressive Agents / administration & dosage
-
Interferon-alpha / therapeutic use*
-
Magnetic Resonance Imaging
-
Male
-
Myelitis, Transverse / complications
-
Myelitis, Transverse / diagnosis
-
Myelitis, Transverse / drug therapy*
-
Spinal Cord / pathology
-
Treatment Outcome
Substances
-
Anti-Bacterial Agents
-
Anti-Inflammatory Agents, Non-Steroidal
-
Glucocorticoids
-
Gout Suppressants
-
Immunologic Factors
-
Immunosuppressive Agents
-
Interferon-alpha